Holen Sie sich die Stockscreener-App
4.41
2.65%
-0.12
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
4.48%
3.752
|
3.591 | 3.887 | 5.462 | 4.168 |
| Operating Income/Loss |
9.38%
-6.983
|
-6.384 | -6.561 | -8.178 | -7.756 |
| Income/Loss From Continuing Operations Before Tax |
10.30%
-6.834
|
-6.196 | -6.334 | -7.948 | 2.773 |
| Income/Loss From Continuing Operations After Tax |
10.30%
-6.834
|
-6.196 | -6.334 | -7.948 | 1.827 |
| Income/Loss From Discontinued Operations, Net Of Tax |
100.00%
-
|
0.293 | - | - | 0.946 |
Net Income/Loss
|
15.77%
-6.834
|
-5.903 | -6.334 | -7.948 | 2.773 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
78.73%
0.6867
|
3.2281 | 12.58 | 6.4822 | 7.0223 |
| Diluted Average Shares |
78.73%
0.6867
|
3.2281 | 12.58 | 6.4822 | 7.0223 |
| Basic Earnings Per Share |
7,007%
-9.95
|
-0.14 | -0.50 | -1.23 | 0.39 |
| Diluted Earnings Per Share |
7,007%
-9.95
|
-0.14 | -0.50 | -1.23 | 0.39 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):